Your browser doesn't support javascript.
loading
Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation.
Giard, Jeanne-Marie; Dodge, Jennifer L; Terrault, Norah A.
Afiliação
  • Giard JM; Université de Montréal, Montréal, Québec, Canada.
  • Dodge JL; Department of Surgery, University of California, San Francisco, San Francisco, CA.
  • Terrault NA; Université de Montréal, Montréal, Québec, Canada.
Liver Transpl ; 25(9): 1310-1320, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31063642
ABSTRACT
Alcohol-associated liver disease (ALD) is the most common indication for liver transplantation (LT) in the United States and Europe. A 6-month alcohol abstinence period has been required by many transplant programs prior to listing, which may influence wait-list (WL) outcomes. Therefore, we examined WL events in patients with ALD versus non-ALD with a special interest in whether these outcomes differed by sex. All US adults listed for LT from January 2002 to December 2016 were eligible except status 1 patients, Model for End-Stage Liver Disease exceptions, retransplants and those with acute alcoholic hepatitis. The outcomes of interest were cumulative WL death or being too sick and WL removal for improvement within 2 years of listing. Competing risk regression models were used to evaluate recipient factors associated with the outcomes. Among the 83,348 eligible WL patients, 23% had ALD. Unadjusted cumulative WL removal within 2 years was 19.0% for ALD versus 21.1% for non-ALD (P < 0.001). In fully adjusted models, ALD was associated with a significantly lower risk of WL removal for death or being too sick (subhazard ratio [SHR], 0.84; 95% confidence interval [CI], 0.81-0.87; P < 0.001) and a higher risk of removal for improvement (SHR, 2.91; 95% CI, 2.35-3.61; P < 0.001) versus non-ALD patients. After adjusting for potential confounders, women with ALD had a higher risk of removal for death or being too sick (SHR, 1.09; 95% CI, 1.00-1.08; P < 0.001) and a higher chance for improvement (SHR, 2.91; 95% CI, 2.35-3.61; P < 0.001) than men with ALD. In conclusion, WL candidates with ALD have more favorable WL outcomes than non-ALD patients with a 16% lower risk of removal for deterioration and 191% higher risk of removal for improvement. This result likely reflects the benefits of alcohol abstinence, but it suggests that listing criteria for ALD may be too restrictive, with patients who might derive benefit from LT not being listed.
Assuntos
Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Listas de Espera / Transplante de Fígado / Doença Hepática Terminal / Abstinência de Álcool / Hepatopatias Alcoólicas Limite: Adolescente / Adulto / Idoso / Feminino / Humanos / Masculino / Meia-Idade / Jovem adulto País/Região como assunto: América do Norte Idioma: Inglês Revista: Liver Transpl Assunto da revista: Gastroenterologia / Transplante Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: Canadá

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Listas de Espera / Transplante de Fígado / Doença Hepática Terminal / Abstinência de Álcool / Hepatopatias Alcoólicas Limite: Adolescente / Adulto / Idoso / Feminino / Humanos / Masculino / Meia-Idade / Jovem adulto País/Região como assunto: América do Norte Idioma: Inglês Revista: Liver Transpl Assunto da revista: Gastroenterologia / Transplante Ano de publicação: 2019 Tipo de documento: Artigo País de afiliação: Canadá